FDA Drug Application (021753) for DIFFERIN by GALDERMA LABS LP

Back to FDA Applications sponsored by GALDERMA LABS LP

Application Number021753
Product Number001
FormGEL;TOPICAL
Dosage0.3%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameDIFFERIN
Active IngredientADAPALENE



Back to FDA Applications sponsored by GALDERMA LABS LP

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.